GSI 150 (Viread 150 mg)
Generic Name: tenofovir
Pill imprint GSI 150 has been identified as Viread 150 mg.
Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GSI 150 (Viread 150 mg)
- Generic Name:
- 150 mg
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Gilead Sciences, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
hypromellose 2910 (15000 mPa.s)
More about Viread (tenofovir)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...